Literature DB >> 15683257

Temperature-dependent variations and intraspecies diversity of the structure of the lipopolysaccharide of Yersinia pestis.

Yuriy A Knirel1, Buko Lindner, Evgeny V Vinogradov, Nina A Kocharova, Sof'ya N Senchenkova, Rima Z Shaikhutdinova, Svetlana V Dentovskaya, Nadezhda K Fursova, Irina V Bakhteeva, Galina M Titareva, Sergey V Balakhonov, Otto Holst, Tat'yana A Gremyakova, Gerald B Pier, Andrey P Anisimov.   

Abstract

Yersinia pestis spread throughout the Americas in the early 20th century, and it occurs predominantly as a single clone within this part of the world. However, within Eurasia and parts of Africa there is significant diversity among Y. pestis strains, which can be classified into different biovars (bv.) and/or subspecies (ssp.), with bv. orientalis/ssp. pestis most closely related to the American clone. To determine one aspect of the relatedness of these different Y. pestis isolates, the structure of the lipopolysaccharide (LPS) of four wild-type and one LPS-mutant Eurasian/African strains of Y. pestis was determined, evaluating effects of growth at mammalian (37 degrees C) or flea (25 degrees C) temperatures on the structure and composition of the core oligosaccharide and lipid A. In the wild-type clones of ssp. pestis, a single major core glycoform was synthesized at 37 degrees C whereas multiple core oligosaccharide glycoforms were produced at 25 degrees C. Structural differences occurred primarily in the terminal monosaccharides. Only tetraacyl lipid A was made at 37 degrees C, whereas at 25 degrees C additional pentaacyl and hexaacyl lipid A structures were produced. 4-Amino-4-deoxyarabinose levels in lipid A increased with lower growth temperatures or when bacteria were cultured in the presence of polymyxin B. In Y. pestis ssp. caucasica, the LPS core lacked D-glycero-D-manno-heptose and the content of 4-amino-4-deoxyarabinose showed no dependence on growth temperature, whereas the degree of acylation of the lipid A and the structure of the oligosaccharide core were temperature dependent. A spontaneous deep-rough LPS mutant strain possessed only a disaccharide core and a slightly variant lipid A. The diversity and differences in the structure of the Y. pestis LPS suggest important contributions of these variations to the pathogenesis of this organism, potentially related to innate and acquired immune recognition of Y. pestis and epidemiologic means to detect, classify, control and respond to Y. pestis infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15683257     DOI: 10.1021/bi048430f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

1.  Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.

Authors:  Henry S Heine; Arnold Louie; Jeffrey J Adamovicz; Kei Amemiya; Randy L Fast; Lynda Miller; Steven M Opal; John Palardy; Nicolas A Parejo; Fritz Sörgel; Martina Kinzig-Schippers; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

2.  Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens.

Authors:  V A Feodorova; L N Pan'kina; E P Savostina; O S Kuznetsov; N P Konnov; L V Sayapina; S V Dentovskaya; R Z Shaikhutdinova; S A Ageev; B Lindner; A N Kondakova; O V Bystrova; N A Kocharova; S N Senchenkova; O Holst; G B Pier; Y A Knirel; A P Anisimov; V L Motin
Journal:  Vaccine       Date:  2009-02-13       Impact factor: 3.641

3.  Automated lipid A structure assignment from hierarchical tandem mass spectrometry data.

Authors:  Ying S Ting; Scott A Shaffer; Jace W Jones; Wailap V Ng; Robert K Ernst; David R Goodlett
Journal:  J Am Soc Mass Spectrom       Date:  2011-03-05       Impact factor: 3.109

4.  Cell-Extrinsic TNF Collaborates with TRIF Signaling To Promote Yersinia-Induced Apoptosis.

Authors:  Lance W Peterson; Naomi H Philip; Christopher P Dillon; John Bertin; Peter J Gough; Douglas R Green; Igor E Brodsky
Journal:  J Immunol       Date:  2016-10-12       Impact factor: 5.422

5.  Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague.

Authors:  Wei Sun; Shilpa Sanapala; Hannah Rahav; Roy Curtiss
Journal:  Vaccine       Date:  2015-10-26       Impact factor: 3.641

6.  Temperature-induced changes in the lipopolysaccharide of Yersinia pestis affect plasminogen activation by the pla surface protease.

Authors:  Marjo Suomalainen; Leandro Araujo Lobo; Klaus Brandenburg; Buko Lindner; Ritva Virkola; Yuriy A Knirel; Andrey P Anisimov; Otto Holst; Timo K Korhonen
Journal:  Infect Immun       Date:  2010-04-05       Impact factor: 3.441

7.  The NLRP12 inflammasome recognizes Yersinia pestis.

Authors:  Gregory I Vladimer; Dan Weng; Sara W Montminy Paquette; Sivapriya Kailasan Vanaja; Vijay A K Rathinam; Marie Hjelmseth Aune; Joseph E Conlon; Joseph J Burbage; Megan K Proulx; Qin Liu; George Reed; Joan C Mecsas; Yoichiro Iwakura; John Bertin; Jon D Goguen; Katherine A Fitzgerald; Egil Lien
Journal:  Immunity       Date:  2012-07-27       Impact factor: 31.745

8.  Surface acoustic wave nebulization facilitating lipid mass spectrometric analysis.

Authors:  Sung Hwan Yoon; Yue Huang; J Scott Edgar; Ying S Ting; Scott R Heron; Yuchieh Kao; Yanyan Li; Christophe D Masselon; Robert K Ernst; David R Goodlett
Journal:  Anal Chem       Date:  2012-07-12       Impact factor: 6.986

9.  Kinetics of innate immune response to Yersinia pestis after intradermal infection in a mouse model.

Authors:  Christopher F Bosio; Clayton O Jarrett; Donald Gardner; B Joseph Hinnebusch
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

10.  RfaL is required for Yersinia pestis type III secretion and virulence.

Authors:  Andrew S Houppert; Lesley Bohman; Peter M Merritt; Christopher B Cole; Adam J Caulfield; Wyndham W Lathem; Melanie M Marketon
Journal:  Infect Immun       Date:  2013-01-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.